Moderna Q4 Earnings and Revenues Beat, COVID Vaccine Sales Decline
MRNA's earnings and revenues surpass estimates in the fourth quarter of 2024. The company reiterates 2025 total revenue ...
News Medical4d
AIM Vaccine submits mRNA RSV vaccine for FDA clinical trials
AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...
AIM Vaccine Mrna RSV Vaccine Submits For Clinical Trials In The U.S. Media Outreach Newswire APAC
HONG KONG SAR - Media OutReach Newswire – 5 February 2025 - AIM Vaccine Co., Ltd. (06660), a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory ...
AIM Vaccine Mrna RSV Vaccine Submits For Clinical Trials In The U.S.
In preclinical animal trials, third-party testing results showed that AIM Vaccine's mRNA RSV vaccine achieved significantly higher levels of specific IgG antibody titers, live-virus neutralizing ...
Moderna questioned on Trump, RFK Jr. impact on vaccine work
Moderna CEO Stéphane Bancel deflected concerns about the new presidential administration's potential impact on life sciences ...
Moderna Norovirus Vaccine Trial on Hold by US FDA Over Neurological Side Effect
Shares of Moderna, along with other vaccine makers, dropped further this year as lawmakers advanced President Donald Trump's ...